Skip to main content
Signal8

Rizo Aleksandra

SEC insider (Form 3/4/5 filer). CIK 0001766210. Director at Syndax Pharmaceuticals Inc (SNDX). 2 reported Form 4/5 transactions since Sep 2024; latest on Feb 4, 2026. Located in NEW YORK, NY.

Companies Rizo Aleksandra has filed insider reports for

  • Syndax Pharmaceuticals Inc (SNDX): Director
Rizo Aleksandra profile photo

Rizo Aleksandra

CIK: 0001766210

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Syndax Pharmaceuticals Inc logo
SNDX

Syndax Pharmaceuticals Inc

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Syndax Pharmaceuticals Inc logo
    SNDX

    Syndax Pharmaceuticals Inc

    Feb 4, 2026
    Award
    Direct
    24K shares-
  • Syndax Pharmaceuticals Inc logo
    SNDX

    Syndax Pharmaceuticals Inc

    Feb 5, 2025
    Award
    Direct
    25K shares-

1-2 of 2